Floatz logo

FLUOROURACILUM

Metastatic Appendix Carcinoma

City of Hope Medical CenterSmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Metastatic Appendix Carcinoma cohort.

Asset / SponsorPhaseRating
Irinotecan
City of Hope Medical Center
Phase 3BB
MITOMYCIN C
City of Hope Medical Center
Phase 3B
Atezolizumab
M.D. Anderson Cancer Center
Phase 2CCC
Apl-5125
Apollo Therapeutics Ltd
Phase 1/2CCC
Sgn-Stnv
Seagen Inc.
Phase 1CC

View all 9 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →